Sana Biotechnology, Inc. 8-K

What Happened
Sana Biotechnology, Inc. (SANA) filed a Form 8-K on May 11, 2026 (Item 2.02) to announce its financial results for the quarter ended March 31, 2026. The company issued a press release reporting its quarterly results; that press release is included in the filing as Exhibit 99.1.

Key Details

• Filing date: May 11, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Period covered: Quarter ended March 31, 2026.
• Exhibit: Press release attached as Exhibit 99.1.
• Cover page interactive XBRL file included (Exhibit 104).

Why It Matters
This 8-K notifies investors that Sana has published its quarterly earnings and related financial information. The filing itself attaches the press release but does not present detailed figures in the 8-K text; shareholders should review Exhibit 99.1 for the specific earnings, revenue, cash position, and any management commentary or guidance. Quarterly results are material for assessing Sana’s operational performance and near-term financial health.